The Pitching Paradox: Jacob deGrom, Pitch Limits, and the Quest for Longevity

Jacob deGrom’s raw talent is undeniable. For a stretch spanning from 2018 to 2021, he posted an ERA+ of 193 while striking out nearly 40% of batters — numbers that belong in the conversation with the greatest multi-year peaks in baseball history. Yet the conversation around deGrom inevitably pivots from dominance to durability. His career has been punctuated by elbow and shoulder injuries, raising a fundamental question: does rigorous pitch count management extend a pitcher’s career, or does the very intensity of deGrom’s mechanics doom even the most carefully monitored workload?

The Injury Resume: A Timeline of Setbacks

To understand the relationship between pitch count management and deGrom’s longevity, one must first map his injury history in detail. DeGrom missed time in 2016 with a lat strain, in 2021 with forearm tightness, and then suffered the most significant blow — a partial tear of the ulnar collateral ligament (UCL) in his right elbow that sidelined him for most of 2022 and required a 2023 return that was cut short by further elbow inflammation. He also dealt with a stress reaction in his right scapula in 2024.

Critically, deGrom’s injuries have rarely occurred in high-pitch-count outings. In fact, many of his most dominant performances — 13-, 14-, and 15-strikeout games — came while he was still under 105 pitches. His 2021 Cy Young season saw him average only 96.7 pitches per start, well below the league average for aces. This suggests that his health issues may stem more from the sheer intensity of each pitch rather than cumulative volume.

The Science of Pitch Count: Beyond the Arbitrary 100

Pitch count management is often reduced to a simple heuristic: “100 pitches and you’re done.” Modern baseball, however, has moved far beyond that. Teams now employ a matrix of factors — velocity drop, spin rate decline, pitch type usage, rest days, and even biomechanical markers from wearable sensors — to determine when a pitcher has reached his limit.

For deGrom, the tracking is amplified because of his history. The New York Mets and now the Texas Rangers have adopted a preventive approach that prioritizes rest and controlled workloads. But the results have been mixed. In 2021, despite strict monitoring, deGrom still landed on the injured list three times. In 2023, the Rangers initially kept him on a 75-pitch limit, then slowly ramped to 80, then 90. Even then, his body broke down after 148 innings across 30 starts over two seasons.

Velocity, Effort, and Tissue Stress

The missing variable in pitch count conversations is effort intensity. DeGrom has averaged 97-99 mph with his four-seam fastball throughout his prime, and his slider and changeup are thrown at elite velocity differentials. Biomechanical studies have shown that throwing at maximum effort for even 40 pitches can generate cumulative microtrauma equivalent to 70-80 pitches at 90% effort. DeGrom frequently throws at or near max velo from the first inning — there is no “settling in” phase. This means that a 90-pitch deGrom start may be biologically analogous to a 115-pitch start from a lower-velocity starter like Kyle Hendricks.

External research supports this. A 2022 study by Dr. Glenn Fleisig at the American Sports Medicine Institute found that pitch count alone accounts for only about 60% of injury risk; the remaining 40% is tied to velocity, arm slot, and torque. For high-velocity pitchers like deGrom, the margin for error in workload management is much thinner.

Comparative Longevity: DeGrom vs. Other Elite Arms

It is instructive to compare deGrom’s trajectory with other high-velocity aces who have managed to sustain longer careers. Max Scherzer is the gold standard — he did not miss significant time until age 38. Scherzer’s secret? He maintained elite velocity but distributed his workload differently: he threw more pitches per start on average (around 105-110) but rarely maxed out effort early in games. He also used a variety of lower-effort breaking balls to disrupt timing without taxing his arm. Justin Verlander similarly evolved, transitioning from a power pitcher to a crafty technician after Tommy John surgery, dropping his fastball usage and increasing reliance on a curveball that he throws with lower elbow torque.

DeGrom, by contrast, has largely refused to change his approach. His fastball usage has remained above 45% even as his velocity has stayed at 99 mph. He has not developed a true changeup that he uses with regularity, and his slider, while devastating, is thrown with high spin and high effort. This makes him a high-risk pitcher regardless of how many pitches he throws.

Data Points: deGrom’s Innings and Pitch Counts

  • 2019: 204 innings, 3,400+ pitches (16.7 per inning) — career high, followed by 2020 short season.
  • 2021: 92 innings, 1,570 pitches — injured after 15 starts despite average 96.7 pitches/start.
  • 2022: 64.1 innings, 1,147 pitches — UCL injury struck in a start where he threw 62 pitches.
  • 2023: 68 innings, 1,210 pitches — again, injury occurred in a low-pitch-count outing.

The pattern is clear: deGrom’s arm breaks down not because of excessive cumulative workload, but because the biological cost of each individual pitch is extraordinarily high. A 90-pitch deGrom start may produce more elbow torque than a 120-pitch start from a league-average pitcher.

How the Rangers and Mets Have Managed the Dilemma

Both organizations have attempted to lengthen deGrom’s career through careful monitoring, but each has learned painful lessons. The Mets often started deGrom on an extra day of rest, especially in 2021-2022, yet injuries still occurred. The Rangers, after signing deGrom to a five-year, $185 million contract, implemented a “pitch count plus effort” system where they monitored not just total pitches but also the peak velocity per pitch sequence and the rate of deceleration in his fastball. They also mandated long-toss sessions on specific schedules and used motion-capture technology to detect subtle changes in arm slot that precede injury.

Yet in June 2024, deGrom suffered a scapula stress reaction — a condition often linked to overuse rather than acute trauma. This suggests that even with the most advanced monitoring, the human body has limits that cannot be entirely mitigated by data. The Rangers have since moved deGrom to a six-man rotation and limited his bullpen sessions to 20-25 pitches, but the long-term viability of this strategy remains untested.

The Role of Strength Training and Recovery Protocols

Pitch count management is only one piece of the longevity puzzle. DeGrom has visibly transformed his physique over the years, adding lean muscle in his legs and core to transfer force more efficiently. However, some experts argue that his relatively high arm slot and extreme scapular retraction create a mechanical environment where the elbow and shoulder are always under stress, regardless of strength. Dr. James Andrews has famously stated that “there is no pitch count that can protect a pitcher with improper biomechanics.” For deGrom, the question becomes: can his mechanics be modified without sacrificing his elite performance?

So far, the answer appears to be no. Every attempt to dial back deGrom’s effort — whether through pitch count limits, rest days, or mechanical adjustment — has either failed to prevent injury or resulted in a drop in stuff. In 2021, when he tried to conserve energy early in games, his fastball velo still averaged 98.5 mph. He simply cannot pitch at 90% without his body reverting to max effort automatically. This is the central tension in the deGrom longevity story: his extraordinary talent demands an extraordinary physical cost.

What Modern Analytics Tells Us About deGrom’s Injury Risk

Advanced metrics like stress load (developed by systems like Motus Global) and arm fatigue index go beyond simple pitch counts. For deGrom, these numbers have consistently been red-flagged. A 2023 analysis by Driveline Baseball showed that deGrom’s elbow varus torque — the force that stresses the UCL — was in the 98th percentile among MLB pitchers even in starts where he threw only 80 pitches. His arm slot, release point, and supination of the forearm combine to produce forces that are nearly impossible to sustain across a full season.

Teams have responded by implementing stricter “pitch count per inning” limits. In 2022, deGrom was pulled from starts if he threw more than 20 pitches in an inning, regardless of total pitch count. This is a radical departure from traditional management, where inning-by-inning efficiency is secondary. But even this micro-management has not eliminated his injury recurrence.

The Ethical and Competitive Dilemma

There is a broader question for baseball: how much should teams intervene in a pitcher’s natural mechanics to extend career longevity? DeGrom himself has expressed frustration at being removed from games when he feels strong. In 2021, he famously argued with manager Luis Rojas after being pulled at 87 pitches with a 10-run lead. The tension between a pitcher’s competitive instinct and the medical staff’s risk assessment is real. “I’m not there just to pitch six innings and then watch the bullpen give it up,” deGrom once said — a sentiment that echoes through generations of competitors.

Yet the data is clear: deGrom’s peak performance comes at a cost that no pitch count can fully manage. The Rangers have taken a particularly aggressive stance, using an algorithm that factors in not just pitches but also exit velocity against his fastball and spin rate decline as markers of fatigue. If his four-seam fastball spin rate drops below 2,400 rpm in a start (his normal is around 2,550), he is immediately removed regardless of count. This represents a new frontier in pitch management — one that deGrom may not fully support but that his contract demands.

Lessons for Baseball: Redefining “Workload”

The deGrom case forces baseball to reconsider its fundamental assumptions about pitcher health. If a pitcher throws only 1,500 pitches in a season but every single one is near-maximum effort, he may be at greater risk than a pitcher who throws 3,200 pitches at lower intensity. This challenges the entire structure of inning limits, pitch counts per start, and even the concept of “rest days.”

Teams are now experimenting with concepts like pitch quality management — limiting high-stress pitches (sliders, high-spin fastballs) while allowing lower-stress offerings (changeups, curveballs) even when a pitcher’s total count is high. For deGrom, this might mean throwing more changeups early in counts to reduce torque. However, this conflicts with his identity as a power pitcher and with the data that shows his changeup is less effective than his fastball-slider combination.

The Future of deGrom’s Career

As of early 2025, Jacob deGrom remains a tantalizing but fragile asset. The Rangers have him on a strict program that includes every-other-day bullpens, weighted-ball drills, and a six-man rotation. He has voiced cautious optimism, but his recent injury history suggests that his window of dominance is narrow. The most optimistic projections see him making 20-25 starts per season for the next two years, with diminished velocity (maybe 96-97 mph) and increased reliance on secondary pitches. The pessimistic view is that another UCL tear is inevitable, requiring Tommy John surgery that would likely end his career at age 36.

Either way, deGrom’s career serves as a powerful case study in the limits of pitch count management. No amount of monitoring can override the fundamental laws of physics: throwing a baseball at 100 mph is an unnatural act that places extreme stress on the elbow and shoulder. The best teams can do is manage that stress, not eliminate it. For deGrom, that means accepting a shorter career by definition — but perhaps one that includes a few more seasons of breathtaking dominance.

Conclusion: The Unresolved Equation

Pitch count management is not a simple formula where X pitches equal Y innings of healthy service. For Jacob deGrom, the variables are more complex: an extreme velocity profile, a high-torque arm slot, a reluctance to change his approach, and a body that appears to have a finite tolerance for elite performance. His longevity — or lack thereof — will continue to inform how teams handle other high-octane arms like Spencer Strider, Hunter Greene, or Grayson Rodriguez. The relationship between pitch count and longevity remains nuanced: it helps, but it cannot override biology or mechanics.

For now, fans are left to appreciate each deGrom start as a rare event — a glimpse of perfection that may end at any moment, regardless of how many pitches he throws.

External References